The number of infections by the tick-borne TBE virus that are not detected by health services is far higher than previously assumed.
Gritgen Therapeutics launches operations at GMP facility in China
Gritgen will begin production of its Phase III clinical and commercial product for haemophilia A. Credit: Sergey Kolesnikov/Shutterstock.com. Gritgen Therapeutics has launched operations at its